Find a trial at the Pfizer Clinical Research Unit

Filter by

Age (years)

5 trials found


A medical device containing 104 mg MPA (medroxyprogesterone acetate) in 0.65 mL suspension for injection and indicated for long-term female contraception via SC injection into the anterior thigh or abdomen every 13 weeks.

In this study the medication will be administrated subcutaneously (under the skin) in one of the following locations: arms, thigh or abdomen. During a subcutaneous injection, a needle is inserted under the skin, rather than into a vein. 

18+ years
Up to € 2.285, plus travel fees
Healthy Chinese participants
Healthy Chinese participants needed

The Pfizer Clinical Research Unit of Brussels will be conducting research studies in the near future with participants of Chinese descent.

Male or Female
18 - 55 years
Compensation for time and transportation costs upon completion of the study
C4671039 Subscriptions still opened

The purpose is to find out how much medication is in breastmilk after intake.

This will help us determine the daily dose a child could potentially be exposed to during breastfeeding, if the nursing mother must take this medicinal product.

18 - 55 years
€ 1.670 upon completion of the study + 120€ for Covid fees and transportation fees 
C5091001 C8 G2
Study on potential treatment of COVID-19

For the potential treatment of COVID-19, a respiratory infection caused by the coronavirus, SARS-CoV-2.

Male or Female
18 - 60 years
Up to € 2.852, plus travel fees.
Sep 01, 2023 - Planned start date (Not yet recruiting)
Study on the potential treatment of adult and pediatric patients with RSV.

The Pfizer Clinical Research Unit Brussels is conducting a study of an investigational drug for a potential treatment of adult and pediatric patients with RSV.

Male or Female
18 ++ years
Up to € 2 258 , plus travel fees

Interested in participating?

Call 0800/99.256 (+32 2 556 70 02 from abroad) or click here to see if you may qualify for our research unit’s ongoing clinical trials

Is this page helpful?